Cutan follicle center lymphoma, extranodal and solid organ sites, is a subtype of non-Hodgkin lymphoma characterized by the proliferation of neoplastic B-cells in lymphoid tissues outside of the lymph nodes. This condition is clinically significant due to its potential for aggressive behavior and varied presentation, necessitating accurate diagnosis and management. The ICD-10 Code C82.69 facilitates precise documentation, billing, and public health reporting, ensuring appropriate care and resource allocation.
ICD-10 Code C82.69 represents cutan follicle center lymphoma occurring in extranodal and solid organ sites. This condition involves malignant transformation of follicle center B-cells, leading to lymphoproliferative disorders outside typical lymphatic structures. This code should be utilized in clinical documentation and billing when diagnosing patients with this specific lymphoma subtype, ensuring accurate representation of the patient's condition.
Cutan follicle center lymphoma, extranodal and solid organ sites, arises from the malignant transformation of B-cells in the follicle center. The etiology is often linked to genetic mutations and environmental factors, leading to a progressive disease that requires prompt medical intervention.
ICD-10 Code C82.69 is integral in SOAP notes for documenting the clinical presentation, assessment, and treatment of patients with cutan follicle center lymphoma. It aids in capturing the complexity of symptoms and guiding therapeutic decisions in both acute and chronic care settings.
In SOAP notes, ICD-10 Code C82.69 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of cutan follicle center lymphoma. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.
Management of cutan follicle center lymphoma, extranodal and solid organ sites, often necessitates hospitalization for comprehensive treatment.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C82.69 is crucial for accurate billing in hospital, ER, or infectious disease care settings.
| CPT Code | Description | 
|---|---|
| 96413 | Chemotherapy administration, intravenous, push technique. | 
| 99223 | Initial hospital care, typically 70 minutes or more. | 
| 85025 | Complete blood count with automated differential. | 
Common Questions About Using ICD-10 Code C82.69 for Cutan folicl center lymphoma, extrnod and solid organ sites
What are the common symptoms of cutan follicle center lymphoma?
Common symptoms include lymphadenopathy, unexplained weight loss, night sweats, and skin lesions. Patients may also experience fatigue and fever, which can indicate disease progression.
How is cutan follicle center lymphoma diagnosed?
Diagnosis typically involves a combination of clinical evaluation, imaging studies, and biopsy of affected tissues to confirm the presence of neoplastic follicle center cells.
What treatment options are available for cutan follicle center lymphoma?
Treatment may include chemotherapy, radiation therapy, and supportive care. The specific regimen depends on the disease's stage and the patient's overall health.
Is cutan follicle center lymphoma curable?
While some patients may achieve remission, the prognosis varies based on factors such as disease stage and response to treatment. Ongoing monitoring is essential.
Clinical Notes
SOAP notes
DAP notes
AI medical notes